lestaurtinib has been researched along with chir 99021 in 1 studies
| Studies (lestaurtinib) | Trials (lestaurtinib) | Recent Studies (post-2010) (lestaurtinib) | Studies (chir 99021) | Trials (chir 99021) | Recent Studies (post-2010) (chir 99021) |
|---|---|---|---|---|---|
| 124 | 12 | 63 | 272 | 1 | 258 |
| Protein | Taxonomy | lestaurtinib (IC50) | chir 99021 (IC50) |
|---|---|---|---|
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 8.8 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 8.8 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 8.8 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 0.0089 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.0133 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 8.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abagyan, R; Balboni, B; Cavalli, A; Demuro, S; Di Martino, RMC; Giabbai, B; Girotto, S; Ortega, JA; Russo, D; Sauvey, C; Shi, D; Storici, P; Tripathi, SK | 1 |
1 other study(ies) available for lestaurtinib and chir 99021
| Article | Year |
|---|---|
ARN25068, a versatile starting point towards triple GSK-3β/FYN/DYRK1A inhibitors to tackle tau-related neurological disorders.
Topics: Binding Sites; Drug Evaluation, Preclinical; Dyrk Kinases; Glycogen Synthase Kinase 3 beta; Humans; Microtubules; Models, Molecular; Neurofibrillary Tangles; Neuroprotective Agents; Phosphorylation; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-fyn; Structure-Activity Relationship; tau Proteins; Tauopathies | 2022 |